Immix Biopharma
ongoing clinical study design in multiple myeloma | Immix Biopharma
Company
Deck Type
Sector
Industry
Deck date
December 2023
Slide
40 of 62
Similar slides by Immix Biopharma
See diffirences between slides (animation)
Investor Presentation
March 2024
ongoing clinical study design as of | Immix Biopharma
Investor Presentation
January 2024
ongoing clinical study design in multiple myeloma | Immix Biopharma
Investor Presentation
November 2023
ongoing clinical study design in multiple myeloma | Immix Biopharma
Investor Presentation
November 2023
ongoing clinical study design in multiple myeloma | Immix Biopharma
Related slides by other companies
CARGO Therapeutics
IPO
March 2024
phase design study of car in | CARGO Therapeutics
GH Research
Investor Presentation
November 2023
design of phase clinical pharmacology trial in healthy volunteers | GH Research
GH Research
Investor Presentation
March 2023
design of phase clinical pharmacology trial in healthy volunteers | GH Research
23andMe
Investor Day
January 2022
phase study design | 23andMe
Other recent decks by Immix Biopharma
See all presentations (11 decks)
Investor Presentation
March 2024
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights